Peab forms associated company with KB Gruppen in Western Norway

Peab and KB Gruppen will merge their Western Norway operations—K. Nordang and Christie & Opsahl—into a new associated company to capture geographic and product synergies; the combined business is expected to generate about NOK 1.9 billion in net sales in 2025 and employ roughly 350 people. KB Gruppen will hold 62.5% and Peab 37.5%, with Peab accounting for the entity as an associated company; K. Nordang (expected NOK 800m sales in 2025) will be sold into the new vehicle at market price, a transaction Peab says will affect its operating profit by about NOK 100 million in Q1 2026. The deal is subject to competition authority approval and is expected to close in Q1 2026.

Analysis

Peab and KB Gruppen will merge Western Norway operations K. Nordang and Christie & Opsahl into a new associated company, with KB Gruppen holding 62.5% and Peab 37.5%. The combined business is expected to generate roughly NOK 1.9 billion in net sales in 2025 and employ about 350 people, with K. Nordang specifically forecast at ~NOK 800 million in 2025.

Peab will sell K. Nordang into the new vehicle at market price and recognize the entity as an associated company; management expects this transaction to affect Peab's operating profit by approximately NOK 100 million in Q1 2026. The closing is conditional on competition authority approval and is targeted for Q1 2026, so timing and potential remedies are key execution points.

The merger targets geographic and product synergies that could bolster regional margins and backlog, but accounting as an associate limits consolidated revenue upside for Peab and shifts emphasis to equity-accounted earnings and one-off sale effects. Primary risks are regulatory approval, integration execution, and the precise accounting/reporting treatment of the sale and the NOK 100 million operating profit impact.

Key Decisions for Investors

• Treat the transaction as a modestly positive structural development for Peab's Norwegian footprint but wait for competition authority approval before adding material exposure
• Adjust near-term models to reflect the expected one-off ~NOK 100 million operating profit impact in Q1 2026 and clarify whether further equity-accounted earnings from the associate will alter recurring EBITDA
• Monitor regulatory outcomes and integration milestones closely and consider hedging or maintaining current positions if approval is delayed or conditional